Clinical Trial Update: VCMX, PRF and SCTG Treatment in the Gingival Recessions [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of VCMX, platelet-rich fibrin (PRF), and subepithelial connective tissue graft (SCTG) for localized gingival…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)
• Subepithelial connective tissue graft
• VCMX

Snippet

Sponsor: Bulent Ecevit University | Conditions: Gingival Recession, Localized | Phase 3 | Status: COMPLETED